Trial
NCT03121417
Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Bristol-Myers Squibb
Condition
Recurrent Non-Small Cell Lung Carcinoma
Intervention
Nivolumab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-21